Complex Segregation Analysis of Primary Hepatocellular Carcinoma in Chinese Families: Interaction of Inherited Susceptibility and Hepatitis B Viral Infection

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1991 Jul 1

PMID 1648308

Citations 16

Authors

F M Shen

M K Lee

H M Gong

X Q Cai

M C King

Affiliations

Soon will be listed here.

Abstract

Primary hepatocellular carcinoma (PHC) is extremely common in eastern China, where it is both associated with chronic infection with hepatitis B virus (HBV) and often familial. Complex segregation analysis of 490 extended families was undertaken with liability classes defined by age, sex, and HBV infection status. The maximum-likelihood model suggests that a recessive allele with population frequency approximately .25 yields lifetime risk of PHC, in the presence of both HBV infection and genetic susceptibility, of .84 for males and .46 for females. The model further predicts that, in the absence of genetic susceptibility, lifetime risk of PHC is .09 for HBV-infected males and .01 for HBV-infected females and that, regardless of genotype, it is virtually zero for uninfected persons. Complex segregation analysis therefore provides evidence for the interaction of genotype, environmental exposure, sex and age in determining the occurrence of PHC in this population.

Citing Articles

Genetic Polymorphisms in CD35 Gene Contribute to the Susceptibility and Prognosis of Hepatocellular Carcinoma.

Luo L, Li Q, Su Z, Li L, Cai B, Peng Y Front Oncol. 2021; 11:700711.

PMID: 34422654 PMC: 8374953. DOI: 10.3389/fonc.2021.700711.

STAT4: an immunoregulator contributing to diverse human diseases.

Yang C, Mai H, Peng J, Zhou B, Hou J, Jiang D Int J Biol Sci. 2020; 16(9):1575-1585.

PMID: 32226303 PMC: 7097918. DOI: 10.7150/ijbs.41852.

A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience.

De Sanctis V, Soliman A, Daar S, Alansary N, Kattamis A, Skafida M Mediterr J Hematol Infect Dis. 2020; 12(1):e2020006.

PMID: 31934316 PMC: 6951357. DOI: 10.4084/MJHID.2020.006.

Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma.

Li Z, Han J, Liu K, Xing H, Wu H, Lau W Hepatobiliary Surg Nutr. 2019; 8(2):88-100.

PMID: 31098356 PMC: 6503234. DOI: 10.21037/hbsn.2018.11.20.

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma.

An P, Xu J, Yu Y, Winkler C Front Genet. 2018; 9:261.

PMID: 30073017 PMC: 6060371. DOI: 10.3389/fgene.2018.00261.

References

Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C . Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991; 350(6317):427-8. DOI: 10.1038/350427a0. View

SUNG J, Chen D . Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan. Scand J Gastroenterol. 1980; 15(3):321-4. DOI: 10.3109/00365528009181477. View

Lok A, Lai C . Factors determining the development of hepatocellular carcinoma in hepatitis B surface antigen carriers. A comparison between families with clusters and solitary cases. Cancer. 1988; 61(7):1287-91. DOI: 10.1002/1097-0142(19880401)61:7<1287::aid-cncr2820610702>3.0.co;2-d. View

Kew M . The development of hepatocellular cancer in humans. Cancer Surv. 1986; 5(4):719-39. View

London W, Buetow K . Hepatitis B virus and primary hepatocellular carcinoma. Cancer Invest. 1988; 6(3):317-26. DOI: 10.3109/07357908809080654. View

Yen F, Shen K . Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res. 1986; 47:297-329. View

Buetow K, Murray J, Israel J, London W, Smith M, Kew M . Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1989; 86(22):8852-6. PMC: 298388. DOI: 10.1073/pnas.86.22.8852. View

Yeh F, Yu M, Mo C, Luo S, Tong M, Henderson B . Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 1989; 49(9):2506-9. View

Hsu H, Wu T, Sheu J, Wu C, Chiou T, Lee C . Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma. Hepatology. 1989; 9(5):747-50. DOI: 10.1002/hep.1840090515. View

10.

Feret E, Larouze B, Diop B, Sow M, London W, Blumberg B . Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. Am J Epidemiol. 1987; 125(1):140-9. DOI: 10.1093/oxfordjournals.aje.a114497. View

11.

Beasley R, Hwang L, Lin C, Chien C . Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256):1129-33. DOI: 10.1016/s0140-6736(81)90585-7. View

12.

Iijma T, Saitoh N, Nobutomo K, Nambu M, Sakuma K . A prospective cohort study of hepatitis B surface antigen carriers in a working population. Gan. 1984; 75(7):571-3. View

13.

Lam K, Yu M, Leung J, Henderson B . Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res. 1982; 42(12):5246-8. View

14.

Blumberg B, London W . Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med. 1981; 304(13):782-4. DOI: 10.1056/NEJM198103263041312. View

15.

Campbell T, Chen J, Liu C, Li J, Parpia B . Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Cancer Res. 1990; 50(21):6882-93. View